drugset / Trial / NCT01466387

A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults

NCT01466387

Phase 3 Completed 552 enrolled Novartis Novartis Vaccines · collab
RandomizedParallel-groupOpen-labelPrevention

Summary

This study compares the safety and immunogenicity profile of several travel vaccines given alone or concomitantly with MenACWY-CRM to healthy adults.

Timeline

Start
2011-11
Primary completion
2012-04
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator IC51 Vaccine
Comparator MenACWY-CRM Vaccine Vaccine
Comparator Rabies vaccine Vaccine
Comparator Typhim Vi Vaccine
Comparator Yellow Fever Vaccine Vaccine